Here is a detailed clinical answer for your 68-year-old dyspnea case:
Deriphyllin + Dexona in a 68-Year-Old with Dyspnea
What are these drugs?
| Drug | Composition | Class |
|---|
| Deriphyllin | Theophylline + Etophylline (7-hydroxyethyltheophylline) | Methylxanthine bronchodilator |
| Dexona | Dexamethasone | Systemic corticosteroid |
WHY are they used in this patient?
Likely diagnosis to consider in a 68-year-old with dyspnea:
- Acute exacerbation of COPD (most common in this age group)
- Bronchial asthma exacerbation
- Cardiac asthma (must rule out)
Deriphyllin - Mechanism & Rationale
Theophylline (the active component of Deriphyllin) works by inhibiting phosphodiesterase (PDE3) in airway smooth muscle cells, which increases intracellular cyclic AMP, causing bronchodilation and airway relaxation.
Additional effects relevant in this elderly patient:
- Anti-inflammatory effect - stimulates histone deacetylase 2 (HDAC2), switching off activated inflammatory genes
- Improves diaphragmatic contractility - particularly valuable in COPD where the diaphragm is fatigued
- Mild respiratory stimulant effect - helpful in dyspnea with hypercapnia
Etophylline (the second component) reduces the adverse effect burden of plain theophylline and contributes additional bronchodilation.
As per Fishman's Pulmonary Diseases: "Theophylline and aminophylline inhibit PDEs in airway smooth muscle cells (predominantly PDE3), which increases intracellular cyclic AMP, leading to a bronchodilator effect."
Dexona (Dexamethasone) - Mechanism & Rationale
Dexamethasone is a potent systemic corticosteroid given in acute exacerbations to:
- Reduce airway inflammation - suppresses eosinophilic/neutrophilic infiltration
- Decrease mucus secretion from bronchial glands
- Restore bronchodilator responsiveness - upregulates beta-2 receptors
- Prevent progression of the exacerbation
In COPD/asthma exacerbations, systemic steroids shorten the duration of the attack and reduce the risk of relapse.
Combination Rationale (Deriphyllin + Dexona)
The combination is used because:
- Bronchodilation (Deriphyllin) + Anti-inflammation (Dexona) = complementary dual action
- In acute dyspnea, both pathways (bronchospasm AND inflammation) need to be addressed simultaneously
- This combination is a widely used Indian emergency/short-term regimen for acute bronchospasm
Important Cautions in a 68-Year-Old
| Concern | Reason |
|---|
| Narrow therapeutic index of theophylline | Elderly have reduced CYP450 clearance - toxicity risk is higher |
| Theophylline toxicity signs | Nausea, vomiting, palpitations, arrhythmias, seizures |
| Dexamethasone (systemic steroid) risks | Hyperglycemia, BP elevation, fluid retention - all amplified in elderly |
| Drug interactions | Erythromycin, ciprofloxacin, allopurinol inhibit CYP450 and raise theophylline levels |
| Cardiac evaluation | In a 68-year-old, dyspnea may be cardiac (heart failure, IHD) - steroids and theophylline can worsen cardiac arrhythmias |
Current Practice Note
Per
Katzung's Basic and Clinical Pharmacology (16th ed.), theophylline is no longer first-line -
short-acting beta-2 agonists (salbutamol/albuterol) + inhaled corticosteroids are preferred for acute exacerbations. Deriphyllin + Dexona is used as an
adjunct or in resource-limited settings where inhalers are not available or not tolerated.
For a 68-year-old, always:
- Rule out cardiac cause of dyspnea first (ECG, BNP)
- Monitor theophylline levels if using for >24 hrs
- Use the shortest effective course of systemic steroids